INOVIO Schedules September Investor Briefings in New York
Biotechnology firm INOVIO, headquartered in Plymouth Meeting, Pennsylvania, is set to engage with the financial community through two upcoming investor conferences this September. The company plans to showcase its pipeline of DNA-based medicines, which are currently being developed to address HPV-related conditions, oncology, and various infectious diseases.
Management will initiate their schedule at the Cantor Global Healthcare Conference in New York on September 9, featuring a fireside chat at 3:20 PM ET. This will be followed by a virtual presentation for the H.C. Wainwright 28th Annual Global Investment Conference, which becomes accessible to the public on September 11 at 7:00 AM ET. Beyond these formal sessions, company representatives will host one-on-one meetings with investors to discuss their proprietary DNA delivery technology, which aims to stimulate the body’s natural disease-fighting responses. Recordings of both conference presentations will remain available online for a period of 90 days following the events.
Comments (0)
No comments yet. Be the first!